BeStock  
Markets › Compare › DFTX vs CRSP

DFTX vs CRSP

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
DFTX · Definium Therapeutics$28.34 ▼ 3.87%
CRSP · CRISPR Therapeutics$39.10 ▲ 0.44%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

56150244338433Nov 24, '25May 26, '26Nov 20, '26
  • DFTX +141.2%
  • CRSP -23.7%

Head to head

MetricDFTXCRSP
Price$28.34$39.10
Change today▼ 3.87%▲ 0.44%
Market cap$3.88B$3.79B
Return, 3 months-34.5%-31.5%
Return, year to date+111.7%-25.4%
Return, 1 year+165.4%-22.2%
P/E (TTM)––
P/B4.02.3
P/E percentile vs own 5y9th53rd
Dividend yield––
Revenue growth (YoY, latest qtr)–+1,325.1%
Net profit growth (YoY)+24.2%-4.7%
Gross margin–-676.9%
Operating margin–-2,221.7%
Net margin–-1,955.7%
Return on equity-61.4%-25.6%
Analyst target vs. price+162.2%+89.9%
Analyst buy share100%67%
RSI (14)3428
30-day volatility69.1%56.0%
Max drawdown, 1 year-41.5%-37.1%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • DFTX is the largest of the group by market value.
  • DFTX has returned the most over the past year.
  • CRSP has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top